TP53 and Sepsis: Emerging options like alkaline phosphatase and L-Carnitine in sepsis-associated AKI, vitamin D in hospitalized AKI, and p53-targeted short interfering RNA in post-cardiac surgery AKI are under investigation, alongside non- pharmacologic interventions such as extracorporeal devices and remote ischemic preconditioning.